Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration

Busatto Filho G, Duran FLS, Squarzoni P, Coutinho AMN, Rosa PGP, Torralbo L, Pachi CGDF, da Costa NA, Porto FHG, Carvalho CL, Brucki SMD, Nitrini R, Forlenza OV, Leite CDC, Buchpiguel CA, de Paula Faria D.

J Neurosci Res. 2021 Feb;99(2):481-501. doi: 10.1002/jnr.24739. Epub 2020 Oct 18.

Retinal imaging in Alzheimer's and neurodegenerative diseases

Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, DeBuc DC, Campbell MCW, Carrillo MC, Chew EY, Cordeiro MF, Dueñas MR, Fernández BM, Koronyo-Hamaoui M, La Morgia C, Carare RO, Sadda SR, van Wijngaarden P, Snyder HM.

Alzheimers Dement. 2021 Jan;17(1):103-111. doi: 10.1002/alz.12179. Epub 2020 Oct 8.

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Schöll M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative.

Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.

Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E.

Crit Rev Clin Lab Sci. 2021 May;58(3):167-179. doi: 10.1080/10408363.2020.1833298. Epub 2020 Nov 2.

The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review

Ramani S, Berard JA, Walker LAS.

J Neurol Sci. 2021 Jan 15;420:117229. doi: 10.1016/j.jns.2020.117229. Epub 2020 Nov 24.

A Multilevel View of the Development of Alzheimer's Disease

Avila J, Perry G.

Neuroscience. 2021 Mar 1;457:283-293. doi: 10.1016/j.neuroscience.2020.11.015. Epub 2020 Nov 24.

The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation

Cisbani G, Bazinet RP.

Prostaglandins Leukot Essent Fatty Acids. 2021 Jan;164:102205. doi: 10.1016/j.plefa.2020.102205. Epub 2020 Nov 19.

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Mimura Y, Nishida H, Nakajima S, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y.

Neurosci Biobehav Rev. 2021 Feb;121:47-59. doi: 10.1016/j.neubiorev.2020.12.003. Epub 2020 Dec 8.

Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis

Chaudhry A, Rizig M.

J Neurol Sci. 2021 Feb 15;421:117270. doi: 10.1016/j.jns.2020.117270. Epub 2020 Dec 15.

Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer's disease biofluid-based biomarker studies

Babulal GM.

J Neurol Sci. 2021 Feb 15;421:117269. doi: 10.1016/j.jns.2020.117269. Epub 2020 Dec 14.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

Blood biomarkers in Alzheimer's disease

Altuna-Azkargorta M, Mendioroz-Iriarte M.

Neurologia (Engl Ed). 2021 Nov-Dec;36(9):704-710. doi: 10.1016/j.nrleng.2018.03.006. Epub 2020 Feb 19.

Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis

Wang W, Li J, Zhang H, Wang X, Zhang X.

Nutr Neurosci. 2021 Jan;24(1):13-22. doi: 10.1080/1028415X.2019.1585506. Epub 2019 Mar 22.

Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders

Benfante R, Di Lascio S, Cardani S, Fornasari D.

Aging Clin Exp Res. 2021 Apr;33(4):823-834. doi: 10.1007/s40520-019-01359-4. Epub 2019 Oct 3.

Alternative splicing in Alzheimer's disease

Biamonti G, Amato A, Belloni E, Di Matteo A, Infantino L, Pradella D, Ghigna C.

Aging Clin Exp Res. 2021 Apr;33(4):747-758. doi: 10.1007/s40520-019-01360-x. Epub 2019 Oct 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias